Member Info for DG12

Target price short term 2.773p. share price for year end 2021 1.141p

The new Eqtec broker's recommendation has stated their shares are a
Speculative Buy, meaning very high risk and possibly they may fail as a company,
and therefore the shares become worthless.

This normally means only invest money you can afford to lose, restricting your

portfolio to a max of 10% of all equity investments held.

https://financial-dictionary.thefreedictionary.com/Speculative+stock

Cobra has only one Biomass renewable energy contract.
No experience on any of their 100 projects working in the UK.
No news of any talks with Eqtec Plc.

https://www.grupocobra.com/en/proyecto/san-pedro-bioenergy-biomasa-plant/

https://www.world-nuclear-news.org/Articles/Sizewell-C-Consortium-signs-MoU-on-investment-pote

Earning per share 5 year growth record in % info from London Stock Exchange
update 25th March 2021.
In order
Active Energy no1 86.6%
Hydrodec 84.2%
SFC 79.1%
AFC 77.6%
Ceres 75.7%
Peer 38.3%
Eqtec 28.0%

Those who got in 1 year ago at 0 .179p are up 1000%. at 1.80p another 10 bagger.

Current share price of 1.80p takes into account 2021 and 2022 profits, profit of 15 million Euro's for 2021 and the predicted profit of 18 million Euros in 2022.
will be announced in April 2022 for 2021 and April 2023 for 2022 results.

June 2020 results showed revenues halved from 1.5 million Euro's
comprising of revenue of 1.5 million Euro's from Spain and 21,531 from the UK in
June 2019 to 770,308 Euro's comprising of 79,145 Euro's from Spain,
691,163 from the USA and zero from the UK.

Shares opened at 2p huge initial spread , bid 1.90p offer 2.10p at 07.55

Align Research share price of 1.39p based on 2020 results.

The profit in research is based on a loss for 2020 of 0.93 million Euro's

The RNS from Eqtec says losses will be AT least 4 million Euro's plus any other
adjustments.

Are the Directors subject to the 50% EU share ownership if they live in a non EU
country ?

http://www.alignresearch.co.uk/ceo-recommendations/

https://www.marketbeat.com/stocks/LON/EQT/

Share.com gives the following recommendations.
Osirium Strong Buy, Greatland Gold Neutral, Kefi Gold strong sell,
Tower resources strong sell, Cyanconnode strong buy, Alba minerals strong buy,
Omega Diag, strong sell, AFC energy and PHE strong sell. Evgen Pharm, strong sell Eqtec strong buy, UK oil and gas strong buy.
Barclays says strong sell Canadian Over and Nuformix and IQ-AI.

https://research-centre.barclays.co.uk/shares/eqtec-cdi/technical-analysis/

https://www.bbc.co.uk/news/science-environment-56503588

Share.com has strong sell recommendation on AFC and PHE

and strong buy on EQT

PM will probably address the Nation at 7pm on 5th April relating to the Covid 19
Roadmap. Note original update was April 12th.
This will inevitably effect share prices on the 6th April.
The main topic is the relaxation of holiday travel abroad from 17th May this date
is expected to be put back.
Main reasons new Covid 19 cases are running at between 100,000-150,000 cases
per month. Target set is well below 30000 per month.
The 3rd wave of cases in Europe, most European countries have seen a 200% increase in cases and the lack of vaccinations, example , The Netherlands , The RIVM Coronavirus program is 350,000 vaccination per week.
They have currently vaccinated 2 million of a total population of 17.5 million.
At that rate the adult population won't be vaccinate for at least 30 weeks .
UK, return of University students , this group is the most at risk of Coronavirus and
therefore their parents are at a higher risk of catching the virus being in the unvaccinated 40-50 age group.
So April 6th could could see wild swings in Share prices.

http://www.alignresearch.co.uk/wp-content/uploads/2020/07/Align_EQTEC_Update_July_2020.pdf
July 2020 research note is based on Billingham being up and running in 2021
and no contract delays.

https://www.share.com/investments-and-recommendations/share-tips-and-search/share-finder